.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Cipla
Dow
Citi
Novartis
Merck
Teva
Express Scripts
Chinese Patent Office

Generated: September 23, 2017

DrugPatentWatch Database Preview

Erythromycin ethylsuccinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin ethylsuccinate and what is the scope of erythromycin ethylsuccinate patent protection?

Erythromycin ethylsuccinate
is the generic ingredient in twelve branded drugs marketed by Alpharma Us Pharms, Arbor Pharms Llc, Ross Labs, Wyeth Ayerst, Parke Davis, Mylan, Ani Pharms Inc, Barr, Pharmafair, Naska, Dista, Arbor Pharms Inc, Pharmacia And Upjohn, and Alra, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are ninety-eight drug master file entries for erythromycin ethylsuccinate. Four suppliers are listed for this compound.

Summary for Generic Name: erythromycin ethylsuccinate

Tradenames:12
Patents:0
Applicants:14
NDAs:22
Drug Master File Entries: see list98
Suppliers / Packagers: see list4
Bulk Api Vendors: see list24
Clinical Trials: see list92
Patent Applications: see list8,105
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:erythromycin ethylsuccinate at DailyMed

Pharmacology for Ingredient: erythromycin ethylsuccinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
GRANULE;ORAL062055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
TABLET;ORAL062847-001Sep 14, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Alpharma Us Pharms
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062200-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
E-MYCIN E
erythromycin ethylsuccinate
SUSPENSION;ORAL062198-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Naska
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062674-001Mar 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062231-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
TABLET;ORAL061904-001Approved Prior to Jan 1, 1982BXRXNoYes► Subscribe► Subscribe► Subscribe
Ross Labs
PEDIAMYCIN
erythromycin ethylsuccinate
GRANULE;ORAL062305-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
WYAMYCIN E
erythromycin ethylsuccinate
SUSPENSION;ORAL062123-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Arbor Pharms Llc
E.E.S. 400
erythromycin ethylsuccinate
TABLET;ORAL061905-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Moodys
Boehringer Ingelheim
Johnson and Johnson
Fuji
Merck
Fish and Richardson
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot